{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:56:01Z","timestamp":1791428161081,"version":"4.3.3"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clml.2024.06.013","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:13:07Z","timestamp":1720419187000},"page":"e808-e818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expression of CD6 in Aggressive NK\/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8761-3170","authenticated-orcid":false,"given":"Xiaoxian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-9053","authenticated-orcid":false,"given":"Chad M.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6366-0480","authenticated-orcid":false,"given":"Jared G.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2889","authenticated-orcid":false,"given":"Sarah L.","family":"Ondrejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-5813","authenticated-orcid":false,"given":"Parnaz","family":"Daneshpajouhnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clml.2024.06.013_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102900","article-title":"Aggressive NK cell leukemia: current state of the art","volume":"12","author":"El Hussein","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"Supplement 1","key":"10.1016\/j.clml.2024.06.013_bib0002","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1182\/blood-2021-154381","article-title":"Epidemiology of aggressive NK-cell leukemia in the United States: a SEER population-based study","volume":"138","author":"Amisha","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2024.06.013_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102699","article-title":"Extranodal natural killer\/T-cell lymphomas: current approaches and future directions","volume":"11","author":"Reneau","year":"2022","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.clml.2024.06.013_bib0004","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2024.06.013_bib0005","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.clml.2024.06.013_bib0006","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.clml.2024.06.013_bib0007","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.clml.2024.06.013_bib0008","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.clml.2024.06.013_bib0009","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000322720","article-title":"The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion","volume":"3","author":"Braun","year":"2011","journal-title":"J Innate Immun"},{"issue":"5","key":"10.1016\/j.clml.2024.06.013_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2017.12.004","article-title":"Clinical and experimental evidence for targeting CD6 in immune-based disorders","volume":"17","author":"Consuegra-Fernandez","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.clml.2024.06.013_bib0011","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145662","article-title":"CD6 is a target for cancer immunotherapy","volume":"6","author":"Ruth","year":"2021","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.clml.2024.06.013_bib0012","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1158\/1078-0432.CCR-08-2533","article-title":"Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers","volume":"15","author":"Wong","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.clml.2024.06.013_bib0013","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1349-7006.2011.02052.x","article-title":"Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis","volume":"102","author":"Uekita","year":"2011","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.clml.2024.06.013_bib0014","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1073\/pnas.1017228108","article-title":"CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.clml.2024.06.013_bib0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/path.4851","article-title":"Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer","volume":"241","author":"Devis","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.clml.2024.06.013_bib0016","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13000-015-0331-z","article-title":"Prognostic significance of ALCAM (CD166\/MEMD) expression in cutaneous melanoma patients","volume":"10","author":"Donizy","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clml.2024.06.013_bib0017","article-title":"The dual role of CD6 as a therapeutic target in cancer and autoimmune disease","volume":"9","author":"Gurrea-Rubio","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.clml.2024.06.013_bib0018","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4103\/ijd.IJD_467_16","article-title":"Itolizumab in Psoriasis","volume":"62","author":"Srivastava","year":"2017","journal-title":"Indian J Dermatol"},{"issue":"10","key":"10.1016\/j.clml.2024.06.013_bib0019","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/s41375-023-01997-8","article-title":"CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma","volume":"37","author":"Parameswaran","year":"2023","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.clml.2024.06.013_bib0020","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41379-022-01091-x","article-title":"Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics","volume":"35","author":"Gisriel","year":"2022","journal-title":"Mod Pathol"},{"issue":"23","key":"10.1016\/j.clml.2024.06.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172914","article-title":"A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders","volume":"8","author":"Zhang","year":"2023","journal-title":"JCI Insight"},{"issue":"20","key":"10.1016\/j.clml.2024.06.013_bib0023","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.clml.2024.06.013_bib0024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","article-title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma","volume":"28","author":"Bouchekioua","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2024.06.013_bib0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.clml.2024.06.013_bib0026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.clml.2024.06.013_bib0027","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/PAS.0000000000001518","article-title":"Genomic and immunophenotypic landscape of aggressive NK-Cell leukemia","volume":"44","author":"El Hussein","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.clml.2024.06.013_bib0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0609.2008.01152.x","article-title":"Expression levels of apoptosis-related proteins and Ki-67 in nasal NK \/T-cell lymphoma","volume":"82","author":"Yasuda","year":"2009","journal-title":"Eur J Haematol"},{"issue":"7","key":"10.1016\/j.clml.2024.06.013_bib0021","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/intimm\/5.7.783","article-title":"Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein","volume":"5","author":"Bott","year":"1993","journal-title":"Int Immunol"},{"issue":"3","key":"10.1016\/j.clml.2024.06.013_bib0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:09:58Z","timestamp":1729595398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2152265024002477"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of CD6 in Aggressive NK\/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}